Top Markets
Coin of the day
Satsuma Pharmaceuticals, Inc. Satsuma Pharmaceuticals, Inc.

Satsuma Pharmaceuticals, Inc.

STSA
Classement en actions #29898
Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm... Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing innovative therapies for the rapid relief of migraines. Its lead therapeutic candidate, STS101, is an integrated drug-device system comprising a proprietary dry-powder formulation of dihydroergotamine mesylate. Currently, STS101 is progressing through its pivotal SUMMIT Phase 3 efficacy trials and is designed for self-administration via a specialized, pre-filled, single-use nasal delivery device. Established in 2016, the company maintains its headquarters in South San Francisco, California.
Prix de l'action
$1.10
Dernière synchronisation: 2023-06-07
Capitalisation boursière
$19.12M
Changement (1 jour)
-0.90%
Changement (1 an)
0.00%
Pays
US
Échange Satsuma Pharmaceuticals, Inc. (STSA)

Catégorie

Historique du prix de l'action pour Satsuma Pharmaceuticals, Inc. (STSA)
Prix de clôture le plus élevé : $1.08 le 2023-06-01

Prix de clôture le plus bas : $15.51 le 2019-09-01
Historique du prix de l'action de Satsuma Pharmaceuticals, Inc. de 2019 à 2026
Performance annuelle du prix de l'action
Année Performance
2023 24.48%
2022 -81.02%
2021 -5.23%
2020 -69.52%
2019 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$527.89 35.09%
US
$996.61 51.72%
NL
$117.42 -19.34%
AU
$737.68 6.34%
CH
$1.07K -5.58%
KR